EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 G

Ensembl ID : ENSLACG00000006736
Gene Symbol: CACNA1G
4 Cross references
197 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSLACG00000007914
Gene Symbol: CACNA1I
3 Cross references
264 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSLACG00000017615
Gene Symbol: CACNA1S
4 Cross references
263 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSLACG00000005450
Gene Symbol: CNR1
4 Cross references
205 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSLACG00000016362
Gene Symbol: CNR2
4 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSLACG00000011724
Gene Symbol: CA12
4 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 13

Ensembl ID : ENSLACG00000001970
Gene Symbol: CA13
3 Cross references
291 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSLACG00000008879
Gene Symbol: CA14
4 Cross references
208 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSLACG00000017298
Gene Symbol: CA4
4 Cross references
79 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSLACG00000015179
Gene Symbol: CA5B
4 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSLACG00000015626
Gene Symbol: CA6
4 Cross references
220 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSLACG00000008012
Gene Symbol: CSNK1E
4 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).